Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Understanding the role of genes in how ALL develops in children
Dr Russell and her team are researching to understand more about the role genes play in how ALL develops so they can find drugs that could specifically target ALL cancer cells.
Understanding why the immune system can go into overdrive in blood cancer
Dr Beth Payne wants to understand why a rare but life threatening condition called Haemophagocytic lymphohistiocytosis (HLH) can develop in some people with blood cancer,
Understanding the role of the bone marrow environment in Myelodysplastic syndromes (MDS)
Dr Mian is researching a group of blood cancer called Myelodysplastic syndromes (MDS) to understand how the cells surrounding cancer cells in the bone marrow help the disease to develop and grow so he can find new ways to treat it.
Investigating whether a protein in the bone marrow could help myeloma grow
Dr Gamez Molina wants to understand whether a protein may help myeloma to develop and grow, and whether it could be used to predict or prevent the disease.
Understanding why some people develop myeloma
Dr Goudswaard is studying proteins in the blood and lifestyle factors to understand why some individuals with MGUS go on to develop myeloma and others in the hope to help identify who might be more at risk.
Mapping the bone marrow to detect blood cancer early
Dr Cooper is using cutting-edge technology understand why some people with Clonal haematopoiesis of indeterminate potential (CHIP) go on to develop blood cancer.
Understanding how the body's immune cells may accidentally help leukaemia cells survive
Dr Kourtzelis wants to understand whether the body's own immune cells may be accidentally helping the cancer to survive so he can find new ways to prevent this from happening.
Understanding why some people with myeloma develop low white blood cell counts during treatment
Dr Sina Beer and Professor Martin Kaiser want to understand why the drug Lenalidomide causes white blood cell counts drop too low in some people and not others to help doctors predict and prevent this side effect.
Developing a new treatment for an aggressive form of acute myeloid leukaemia (AML)
Professor Erika Mancini wants to test a drug that means cancerous cells are unable to repair themselves if they become damaged in the hope of creating a new way to treat AML.
Preventing and treating infections in patients with blood cancer following CAR-T cell therapy
Read more how Dr Hamilton and his team are researching better ways to prevent, detect, and treat infections in people with blood cancer that is more tailored to each person’s needs.
Targeting a protein to treat acute myeloid leukaemia (AML) in children
Dr Keeshan is researching to see if removing or blocking a specific protein can help make it easier to treat children with acute myeloid leukaemia (AML).
Breaking down a protein that myeloma needs to survive
Dr Adrain wants to find new ways to target a protein that myeloma cells rely on to survive, with the hope of developing new treatments for people with myeloma
Understanding how umbilical cord stem cells could make transplants more accessible for people with blood cancer
Dr Grey and Dr Masoumi want to better understand how stem cells work and find new ways to grow them from umbilical cord blood so they can be made more accessible for people who need them.
Testing a new type of drug that could stop blood cancer cells from growing
Dr Batta wants to find a new and more precise way to stop a protein from being made, which he hopes will provide a new treatment for people with blood cancer in the future.
Understanding why mantle cell lymphoma comes back after treatment
Dr Oscar Atkins wants to understand more about why mantle cell lymphoma comes back after treatment to identify ways to stop the disease from returning.
Growing a spleen in a dish to understand how it protects leukaemia cells from treatment
Dr Lisi-Vega has developed a new way to grow spleen tissue in the laboratory to understand how the spleen helps cancer cells survive.
A new approach to a treating fatigue in people with chronic lymphocytic leukaemia (CLL)
Dr Bartlett and his team at the University of Surrey are testing whether a personalised, home-based program focusing on exercise and diet can reduce fatigue and improve quality of life.
Advancing CAR-T cell therapy to transform treatment and provide hope for people with myeloma
Dr Charlotte Graham's clinical trial is testing a new type of CAR-T cell therapy to find a new way to treat myeloma.
A new combination of drugs to treat Primary Central Nervous System Lymphoma (PCNSL)
Professor Fox and team are testing a new drug combination that aims to better target and treat cancer cells.
A new treatment for myeloma
Dr Alanna Green is testing a new drug that could offer a more effective way to treat myeloma and improve patient outcomes.
A new way of diagnosing and monitoring myeloma
Non-measurable myeloma (NMM) is a type of myeloma that can be hard to detect via a blood test. Dr Chan and her team are developing a new technique to diagnose and monitor people with this type of myeloma.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.